cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
Before testing new therapies in animals, researchers now have a more efficient starting point—lab-grown canine muscle cells ...
Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil exposure. These infections can affect both healthy and immunocompromised ...
The global Urinary Tract Infection Testing Market is entering a period of sustained expansion as healthcare systems ...
Pee™•Dx Urine Collection Kit for at-home sample collection with Roche’s cobas® molecular lab testing equipment ...
By integrating Evosep’s high-throughput LC platform with Molecular You’s multi-omic analytics and interpretation engine, the ...
American Journal of Transplantation publishes public pre-proof showing novel CM-score superior to either fractional or absolute measurement of dd-cfDNA aloneGraftAssure assay doubles reliability of po ...
Hosted on MSN
Insight Molecular Diagnostics outlines $1B transplant testing market expansion as company nears FDA submission
Earnings Call Insights: Insight Molecular Diagnostics Inc. (IMDX) Q3 2025 CEO Joshua Riggs highlighted that Insight Molecular Diagnostics is nearing a transformative milestone, stating, "In 2026, with ...
Please provide your email address to receive an email when new articles are posted on . Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with ...
Multiple events and presentations will highlight potential benefits of in-house transplanted-organ-rejection testing, and of GraftAssure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results